These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C. Biol Psychiatry; 1997 Jun 01; 41(11):1071-86. PubMed ID: 9146818 [Abstract] [Full Text] [Related]
3. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Terao T, Yoshimura R, Ohmori O, Takano T, Takahashi N, Iwata N, Suzuki T, Abe K. Biol Psychiatry; 1997 May 01; 41(9):974-8. PubMed ID: 9110103 [Abstract] [Full Text] [Related]
4. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE. Biol Psychiatry; 1995 May 15; 37(10):740-9. PubMed ID: 7640329 [Abstract] [Full Text] [Related]
7. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Nappi RE, Sances G, Brundu B, De Taddei S, Sommacal A, Ghiotto N, Polatti F, Nappi G. Hum Reprod; 2005 Dec 15; 20(12):3423-8. PubMed ID: 16123089 [Abstract] [Full Text] [Related]
9. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS. Arch Gen Psychiatry; 1994 Nov 15; 51(11):898-911. PubMed ID: 7944878 [Abstract] [Full Text] [Related]
10. Estrogen augments serotonergic activity in postmenopausal women. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Biol Psychiatry; 1995 Apr 01; 37(7):434-41. PubMed ID: 7786956 [Abstract] [Full Text] [Related]
14. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Alcohol Clin Exp Res; 2000 Jan 01; 24(1):67-71. PubMed ID: 10656195 [Abstract] [Full Text] [Related]
15. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers. Kühn KU, Quednow BB, Bagli M, Meyer K, Feuchtl A, Westheide J, Frahnert C, Maier W, Rao ML. Pharmacopsychiatry; 2002 Nov 01; 35(6):226-30. PubMed ID: 12518270 [Abstract] [Full Text] [Related]
17. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B. Biol Psychiatry; 1996 Sep 15; 40(6):508-13. PubMed ID: 8879471 [Abstract] [Full Text] [Related]
18. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Ehrenreich H, Schuck J, Stender N, Pilz J, Gefeller O, Schilling L, Poser W, Kaw S. Alcohol Clin Exp Res; 1997 Oct 15; 21(7):1285-93. PubMed ID: 9347091 [Abstract] [Full Text] [Related]
19. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. Mueller EA, Murphy DL, Sunderland T. J Clin Endocrinol Metab; 1985 Dec 15; 61(6):1179-84. PubMed ID: 4055985 [Abstract] [Full Text] [Related]
20. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. Hadigan CM, Walsh BT, Buttinger C, Hollander E. Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]